IL1RN and duodenal ulcer: Interleukin-1β (IL1β) and interleukin-1 receptor antagonist (IL1RN) gene polymorphisms have been found to be associated with increased risk of AG, GC and duodenal ulcer (DU) [4, 5], but contradictory results have been reported [6, 7].